PTC Therapeutics Inc (PTCT)
42.38
-1.65
(-3.75%)
USD |
NASDAQ |
Nov 14, 16:00
42.40
+0.02
(+0.05%)
After-Hours: 20:00
PTC Therapeutics Gross Profit (Annual): 872.34M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 872.34M |
| December 31, 2022 | 654.12M |
| December 31, 2021 | 506.26M |
| December 31, 2020 | 361.82M |
| Date | Value |
|---|---|
| December 31, 2019 | 294.84M |
| December 31, 2018 | 252.06M |
| December 31, 2017 | 189.82M |
| December 31, 2016 | 82.70M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
294.84M
Minimum
2019
872.34M
Maximum
2023
537.88M
Average
506.26M
Median
2021
Gross Profit (Annual) Benchmarks
| Pfizer Inc | 33.54B |
| Vertex Pharmaceuticals Inc | 8.607B |
| BridgeBio Pharma Inc | 6.857M |
| Cassava Sciences Inc | -- |
| Regeneron Pharmaceuticals Inc | 11.30B |